LSL Pharma Group Inc. (TSXV:LSL) entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million on May 6, 2024. The CAD 2.5 million purchase price, to be paid in cash only, will be funded by the proceeds from the recently completed private placements, includes a fully operational manufacturing plant. LSL Pharma anticipates closing the transaction by the end of Q2-2024.

Upon signing of the LOI, LSL Pharma was required to make a non-refundable payment of CAD 0.1 million.